The Story Of Our Firm | En Español
 Home    Lawyers   Litigation   Choose Us   Settlements   Search

Previous Investigations Other Litigations Xigris Research Center

Breaking News

in this section: Breaking News


Bookmark This Page Print This Page Email This Page

Xigris Breaking News

Xigris is supposed to treat sepsis, but it does no more than a placebo, with severe side effects. Keep up to date with Xigris and Eli Lilly with the following news articles. If you or a loved one has suffered due to Xigris, fill out this simple form for a free, non-obligitory case review within 24 hours.


Study: Lilly's Xigris didn't help patients with mild sepsis

September 29, 2005 (indystar.com)

Indianapolis (Bloomberg) -- Eli Lilly and Co.'s Xigris failed to benefit patients with mild cases of sepsis, a potentially fatal blood infection, a company-funded study found.

The Food and Drug Administration approved Xigris for marketing in 2001 based on a study showing the drug reduced death rates from severe forms of sepsis. The agency restricted Xigris' use to the highest-risk patients and asked Lilly to conduct additional research to see if it helped patients with milder forms of the condition.


Study Rules Out Xigris in Low Death-Risk Sepsis Patients

September 28th, 2005 (medpagetoday.com)

DENVER, Sept. 28-Xigris (drotrecogin alfa, activated) should not be used in patients with severe sepsis but a low risk of death, researchers have concluded. A large, prospective, randomized, placebo-controlled Phase 4 trial of Xigris was stopped early because there was no evidence of a beneficial effect and there was an increased incidence of serious bleeding complications among patients receiving the drug, said Edward Abraham, M.D., of the University of Colorado Health Sciences Center here.




Weitz & Luxenberg is no longer accepting new Xigris cases.


see also:

Breaking News Eli Lilly's Xigris Lawsuit Reseach Center: Xigris Breaking News
Xigris Lawsuit Research: Eli Lilly's Xigris Breaking News provided by Xigris Lawyers

News & Warnings Xigris Lawsuit Reseach Center: Xigris News & Warnings
Xigris Lawsuit Research: Xigris News & Warnings provided by Xigris Lawyers

Free Legal Review:
Name:
Phone:
Email:
Case Description:



For legal help anywhere in the U.S.
Ask a Free Question:
Were you injured?

check for your response [login]
$53 million verdict — brake mechanic suffering from mesothelioma

$13.5 million verdict — one of the very first Vioxx trial cases

$15 million settlement — man wound up a paraplegic due to negligent hospital care

$37 million verdict — 2 asbestos lung cancer plaintiffs

$47 million verdict — boilermaker who died from mesothelioma

$2.6 million settlement — ill-fitting prosthesis caused decubitus ulcers

$75 million verdict — historic consolidated trial involving men who had worked at the Brooklyn Navy Yard in the 1940s and 1950s

$12.7 million verdict — iron worker who was injured due to unsafe working conditions

$8 million settlement — obstetrical malpractice resulted in neurological deficits

$64.65 million award — 4 asbestos plaintiffs

$17.5 million — consolidated trial of 5 mesothelioma victims